Shares of Kiniksa Pharmaceuticals, Ltd. KNSA surged 18.3% after the company reported that Phase 2 trial of mavrilimumab in giant cell arteritis had achieved both the primary and secondary efficacy endpoints with statistical significanceGamida Cell Ltd.’s GMDA shares jumped 9.5% after the company announced that its Phase 3 clinical study of Omidubicel met all three of its secondary endpoints.Shares of BioNTech SE BNTX rose 6.1% after the company and Pfizer reported the initiation of rolling submission to the EMA for SARS-CoV-2 vaccine candidate BNT162b2.Naked Brand Group Limited’s NAKD shares jumped 5.7% after the company announced that its subsidiary, Bendon, has entered into a settlement deal with Timothy Connell, William Gibson and Ivory Castle.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Naked Brand Group Limited (NAKD): Get Free Report Kiniksa Pharmaceuticals, Ltd. (KNSA): Free Stock Analysis Report Gamida Cell Ltd. (GMDA): Free Stock Analysis Report BioNTech SE Sponsored ADR (BNTX): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research